Publicação: Heterocyclic N-oxides -A promising class of agents against tuberculosis, malaria and neglected tropical diseases
dc.contributor.author | Fernandes, Guilherme Felipe dos Santos [UNESP] | |
dc.contributor.author | Pavan, Aline Renata [UNESP] | |
dc.contributor.author | dos Santos, Jean Leandro [UNESP] | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2018-12-11T16:54:21Z | |
dc.date.available | 2018-12-11T16:54:21Z | |
dc.date.issued | 2018-01-01 | |
dc.description.abstract | Heterocyclic N-oxides have emerged as promising agents against a number of diseases and disorders, especially infectious diseases. This review analyzes the emergence and development of this scaffold in the medicinal chemistry, focusing mainly on the discovery of new heterocyclic N-oxide compounds with potent activity against tuberculosis, malaria and neglected tropical diseases (i.e. leishmaniasis and Chagas disease). A number of heterocyclic N-oxides are described herein, nevertheless, the following chemical classes deserve to be highlighted due to a large number of reports in the literature about their promising pharmacological effects: furoxan, benzofuroxan, quinoxaline 1,4-di-N-oxide, indolone N-oxide and benzimidazole N-oxide. In order to describe those most promising compounds, we included in this review only those most biologically active heterocyclic Noxide published since 2000. | en |
dc.description.affiliation | São Paulo State University (UNESP) School of Pharmaceutical Sciences | |
dc.description.affiliation | São Paulo State University (UNESP) Institute of Chemistry | |
dc.description.affiliationUnesp | São Paulo State University (UNESP) School of Pharmaceutical Sciences | |
dc.description.affiliationUnesp | São Paulo State University (UNESP) Institute of Chemistry | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorshipId | FAPESP: 2015/19531-1 | |
dc.description.sponsorshipId | FAPESP: 2015/21252-3 | |
dc.description.sponsorshipId | FAPESP: 2016/09502-7 | |
dc.format.extent | 1325-1340 | |
dc.identifier | http://dx.doi.org/10.2174/1381612824666180417122625 | |
dc.identifier.citation | Current Pharmaceutical Design, v. 24, n. 12, p. 1325-1340, 2018. | |
dc.identifier.doi | 10.2174/1381612824666180417122625 | |
dc.identifier.issn | 1873-4286 | |
dc.identifier.issn | 1381-6128 | |
dc.identifier.scopus | 2-s2.0-85049665999 | |
dc.identifier.uri | http://hdl.handle.net/11449/171198 | |
dc.language.iso | eng | |
dc.relation.ispartof | Current Pharmaceutical Design | |
dc.relation.ispartofsjr | 0,883 | |
dc.rights.accessRights | Acesso restrito | pt |
dc.source | Scopus | |
dc.subject | Chagas disease | |
dc.subject | Drug discovery | |
dc.subject | Heterocyclic N-oxides | |
dc.subject | Leishmaniasis | |
dc.subject | Malaria | |
dc.subject | N-oxide compounds | |
dc.subject | Neglected tropical diseases | |
dc.subject | Tuberculosis | |
dc.title | Heterocyclic N-oxides -A promising class of agents against tuberculosis, malaria and neglected tropical diseases | en |
dc.type | Resenha | pt |
dspace.entity.type | Publication | |
relation.isOrgUnitOfPublication | 95697b0b-8977-4af6-88d5-c29c80b5ee92 | |
relation.isOrgUnitOfPublication.latestForDiscovery | 95697b0b-8977-4af6-88d5-c29c80b5ee92 | |
unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquara | pt |
unesp.campus | Universidade Estadual Paulista (UNESP), Instituto de Química, Araraquara | pt |